-
FDA indicated to Capricor that it will be unable to approve Deramiocel without additional data
Capricor Therapeutics announced that it has received a Complete Response Letter indicating that the FDA […]
-
Expedia’s New Initiative is Transforming Accessibility for Short-Term Rentals
Lorraine Woodward, founder and CEO of Becoming rentABLE. Expedia Group is not only opening the […]
-
Capricor Therapeutics Receives Complete Response Letter Regarding Deramiocel (CAP-1002)
On July 9th, the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter […]
-
Post AAV Gene Therapy Resources
As therapeutic options for Duchenne advance, we are seeing continued development of additional AAV gene […]
-
Moderate pain reported by a third of muscular dystrophy patients
Nearly one-third of people with muscular dystrophy (MD) experience moderate pain, which varies by the […]
-
Connecting with Experts via PPMD For You
Need direct support for yourself or your child living with dystrophinopathy? PPMD’s PPMD For You program […]
-
A program for youth leaders leaves me optimistic for the future
A couple weeks ago, I had the privilege of participating in a unique event designed […]
-
Quest Podcast: Unpacking Disability Pride- Voices from the MDA Community
In this Quest Podcast episode, we chat with MDA Ambassadors, Payton Rule, Fred Graves and […]
-
Households caring for DMD patients face high costs: US survey
Households incur substantial costs to accommodate people with Duchenne muscular dystrophy (DMD), according to a […]
-
In Case You Missed It…
Quest Media is an innovative adaptive lifestyle platform from MDA. With the power of this […]
